Table 3.
Accuracy of NfL at 95 and 80% sensitivity for prediction of good outcome
| Time point | N | 95% sensitivity | 80% sensitivity | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Specificity % | Cut-off, pg/mL | NPV% | PPV% | Specificity % | Cut-off, pg/mL | NPV% | PPV% | pAUROC 80–95% | |||
| OHCA | 0 h | 289 | 20 (7–31) | 7 | 62 | 73 | 60 (45–72) | 12 | 56 | 82 | 0.66 |
| 12 h | 300 | 71 (59–81) | 23 | 86 | 87 | 88 (77–95) | 45 | 67 | 93 | 0.88 | |
| 48 h | 210 | 74 (64–88) | 53 | 88 | 89 | 100 (94–100) | 388 | 69 | 100 | 0.95 | |
| IHCA | 0 h | 83 | 16 (3–26) | 9 | 75 | 57 | 37 (11–55) | 16 | 64 | 61 | 0.55 |
| 12 h | 87 | 13 (0–47) | 9 | 63 | 58 | 55 (29–92) | 27 | 68 | 70 | 0.64 | |
| 48 h | 54 | 37 (11–68) | 30 | 78 | 73 | 79 (42–95) | 91 | 68 | 88 | 0.75 | |
Specificities with 95% CI, cut-offs, negative predictive values (NPV), and positive predictive values (PPV) at pre-defined high sensitivities (95% and 80%) for neurofilament light (NfL) on admission (0 h), 12 and 48 h after OHCA and IHCA. The pAUROC presents performance of NfL in the 80–95% sensitivity range. A 95% sensitivity indicates that 5% of the patients with poor outcome had NfL levels below the cut-off. OHCA out-of-hospital cardiac arrest, IHCA in-hospital cardiac arrest, pAUROC partial area under the receiver operating curve